FMR LLC 13D and 13G filings for Theseus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-10 08:19 am Sale |
2023-08-09 | 13G | Theseus Pharmaceuticals, Inc. THRX |
FMR LLC | 1,194 0.002% |
-2,497,161 (-99.95%) |
Filing |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | Theseus Pharmaceuticals, Inc. THRX |
FMR LLC | 2,498,355 6.453% |
-694,308 (-21.75%) |
Filing |
| 2022-12-12 08:41 am Sale |
2022-12-09 | 13G | Theseus Pharmaceuticals, Inc. THRX |
FMR LLC | 3,192,663 8.246% |
-2,256,006 (-41.40%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Theseus Pharmaceuticals, Inc. THRX |
FMR LLC | 5,448,669 14.078% |
1,494,953 (+37.81%) |
Filing |
| 2021-11-10 12:24 pm Purchase |
2021-11-09 | 13G | Theseus Pharmaceuticals, Inc. THRX |
FMR LLC | 3,953,716 10.534% |
3,953,716 (New Position) |
Filing |